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Introduction: Rosai-Dorfman disease, also known as sinus histiocytosis with massive lymphadenopathy, is a rare
benign disorder characterized histologically by lymphatic sinus dilatation due to histiocyte proliferation.
Rosai-Dorfman disease accompanied by IgG4+ plasma cell infiltration is an even rarer situation. To the best of our
knowledge, no imaging report of fluoro-deoxyglucose positron emission tomography/computed tomography
findings of Rosai-Dorfman disease with IgG4+ plasma cell infiltration has been published, although a series of
pathological research has focused on this phenomenon.
Case presentation: We reviewed the 18F-fluoro-deoxyglucose positron emission tomography/computed
tomography scan of a 78-year-old Chinese woman with a solid mass that was found in her right breast during a
health checkup. 18F-fluoro-deoxyglucose positron emission tomography/computed tomography showed a
hypermetabolic nodule in her right breast and slightly heterogeneous increased fluoro-deoxyglucose uptake of the
pulmonary nodules, which were histologically proven to be mammary Rosai-Dorfman disease with IgG4+ plasma
cell infiltration and pulmonary amyloidosis, respectively. A literature review was performed to gather information on
this rare disease process.
Conclusions: Although distinguishing benign lymphoplasmacytic proliferation from malignancy may be difficult
with 18F-fluoro-deoxyglucose positron emission tomography/computed tomography in light of the pattern and
intensity of fluoro-deoxyglucose uptake, our case highlights that whole-body positron emission tomography/
computed tomography imaging not only can display the extent of the disease to help complete staging but also
can provide functional information about disease activity to guide biopsy.
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Figure 1 Maximum intensity projection image of a 78-year-old
woman with Rosai-Dorfman disease accompanied by IgG4+
plasma cell infiltration. Besides the hypermetabolic lesion of the
right breast, mild 18F-fluoro-deoxyglucose uptake was illustrated at
the hila of the lungs and neck bilaterally.
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Rosai-Dorfman disease (RDD), also known as sinus his-
tiocytosis with massive lymphadenopathy, is a rare be-
nign disorder characterized histologically by lymphatic
sinus dilatation due to histiocyte proliferation. The di-
sease was first described by Destombes in 1965 [1] and
was recognized as a distinct clinicopathological entity by
Rosai and Dorfman in 1969 [2]. The etiology of this di-
sease remains unclear; speculation has centered on a
histiocytic reaction induced by cytokines or an as-yet-
unidentified infection [3]. Clinically, RDD affects mostly
children and young adults, who may present with fever,
chills, and signs of systemic illness [4]. Typically, lympha-
denopathy of RDD involves the cervical region. However,
43% of cases are associated with extranodal involvement
[5]. RDD demonstrates a broad range of clinical presen-
tations from no symptoms to xanthomatous skin, skin
nodules, regional lymphadenopathy, and visceral mass
and even death if lesions infiltrate to vital organs [6,7].
Pathologically, the characterizing feature of RDD is em-
peripolesis, a phenomenon that presents as variable num-
bers of intact lymphocytes within the cytoplasm of
distinctive enlarged histiocytes. Immunohistochemical
staining positive for S-100 and CD-68 protein and nega-
tive for CD1a is specific to and a prerequisite for the diag-
nosis of RDD [3,5,8].
IgG4-related sclerosing disease (IgG4-RSD) is a syn-
drome characterized by the involvement of a wide variety
of tissues by lymphoplasmacytic infiltrates and sclerosis,
elevated serum IgG4 titer, and increased IgG4+ plasma
cells in tissues [9]. One or more sites, including the
pancreas and retroperitoneum, could be involved in this
entity. Recently, the possible relationship between RDD
and IgG4-RSD was proposed [10]. However, although the
diagnosis of both RDD and IgG4-RSD relies on patho-
logical proof from the involved tissues and typical labora-
tory findings, integrated positron emission tomography/
computed tomography (PET/CT) as a whole-body ima-
ging tool has proven to be a valuable imaging technique
for distinguishing neoplastic from benign lesions and
evaluating the extent and processes of the disease. We re-
port a case of RDD with abundant IgG4+ plasma cell infil-
tration with a fluorine-18-fluoro-deoxyglucose (18F-FDG)
PET/CT scan. To the best of our knowledge, this is the
first report of such a case.
Case presentation
A 78-year-old Chinese woman had an isolated mass that
was found in her right breast during a health checkup,
and a pulmonary CT scan revealed multiple lesions in
both of her lungs. She had a history of cough and ex-
pectoration for two months without fever, chest pain,
dyspnea, or other complaints. During a physical examina-
tion, a nearly 2.0×2.0cm, firm nodule without tendernesswas found in the lateral superior quadrant of the right
breast. In a routine blood test and tumor marker screen,
no remarkable abnormalities were reported. However, the
anti-SS-A and anti-SS-B antibodies were positive. Our pa-
tient had high concentrations of polyclonal serum immu-
noglobulins (Igs): IgA 485.00mg/dL (reference range: 70
to 400mg/dL), IgG 2030.00mg/dL (reference range: 700 to
1600mg/dL), Ig light-chain kappa 432.00mg/dL (reference
range: 170 to 370mg/dL), and Ig light-chain lambda
249.00mg/dL (reference range: 90 to 210mg/dL).
Prior to a surgical resection of the mammary nodule, a
whole-body PET/CT scan was suggested for the purpose
of staging the possible malignant breast lesion. The scan
was performed on a PET/CT system (Siemens Biograph
TruePoint™ 64; Siemens Healthcare, Erlangen, Germany)
at 60 minutes after intravenous injection of 6.5mCi
(240MBq) of 18F-FDG and covered the range of the bot-
tom of the skull to the mid thigh. On the PET maximum
intensity projection image (Figure 1), an obviously hy-
permetabolic nodule in the right breast and slightly
increased FDG uptake of the lymph nodes (LNs) at the
hilus of the lungs and posterior cervical region bilaterally
were revealed. On transverse images of PET/CT, the right
breast lesion was a 2.3×1.9cm, round, well-circumscribed
Figure 2 Computed tomography (CT) (A), 18F-fluoro-deoxyglucose positron emission tomography (FDG-PET) (B), and fused PET/CT
(C) images of the mammary lesion. Axial images show a 2.7×2.5cm, well-circumscribed, soft-tissue nodule with obvious FDG uptake
(SUVmax of 7.30) in the right breast (arrows).
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dized uptake value (SUVmax) of 7.30 (Figure 2). Multiple
irregular nodules with slight to mild FDG uptake were
observed in the lungs, and the largest lesion was a
2.7×2.5cm, round, well-defined solid nodule in the right
lower lobe and had an SUVmax of 2.96 (Figure 3). In
addition, the bilateral posterior cervical LNs were normal
in size and had an SUVmax of 4.48. Given the multiple
FDG-avid foci in a woman of our patient’s age, a primary
breast malignant tumor lesion with pulmonary metastasis
was considered first and surgery on the mammary lesion
was performed three days later.
Tissues of the mammary lesion were reviewed for his-
topathological features, and formalin-fixed and paraffin-
embedded tissues were immunostained with antibodies to
IgG4 (1:300, clone HP6025; Zymed, now part of Invitrogen
Corporation, Carlsbad, CA, USA), IgG (1:200, clone A57H;Figure 3 Computed tomography (CT) lung window (A), CT mediastina
tomography (FDG-PET) (C), and fused PET/CT (D) images of the pulm
with mild ring-like FDG uptake (SUVmax of 2.96) in the right upper lobe ofDako, Glostrup, Denmark), S-100 protein (1:1000, poly-
clonal; Dako), and CD68 protein (1:100, clone KP1; Dako).
Congo red stain was used to test amyloid deposits. Patho-
logically, the mammary lesion showed abundant plasma
cells and sinus histiocytes, including large pale pathogno-
monic histiocytes that exhibited emperipolesis (Figure 4A).
In addition, lymphoid follicle formation, patchy fibrosis,
and obliterative phlebitis, accompanied by atrophy and loss
of mammary lobules, were observed. Further immunohis-
tochemical staining showed large histiocytes positive for
S-100 protein (Figure 4B) and CD-68 protein but negative
for CD1a. The average number of IgG4+ cells was 118 per
high-powered field, and the ratio of IgG4+ to IgG+ cells
was 65%.
The lesion in the upper lobe of the right lung and the
LN at the right carotid sheath were biopsied. Histology re-
vealed deposition of strongly Congo red-positive materialsl window (B), 18F-fluoro-deoxyglucose positron emission
onary lesion. Axial images show a round, relatively isodense lesion
the lung (arrows).
Figure 4 Histopathological images and immunohistochemical staining of the mammary lesion. (A) High-power photomicrograph shows
distinctive histiocytes of Rosai-Dorfman disease that are large with abundant and finely granular pink cytoplasm and relatively large nuclei with
open chromatin and distinct nucleoli. Engulfment of intact lymphocytes and plasma cells by the large histiocytes, a phenomenon known as
emperipolesis (arrow), is shown (stain: hematoxylin-eosin; original magnification: ×400). (B) Immunohistochemical staining for IgG4 labels most of
the plasma cells (IgG immunohistochemical stain counterstained by hematoxylin-eosin; original magnification: ×400).
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lung tissue. Reactive lymphoproliferation and deposition
of Congo red-positive materials within the adjacent con-
nective tissue were observed in the cervical LN.
Discussion
The use of 18F-FDG PET has evolved in the last few dec-
ades and is now considered one of the mainstays of diag-
nosis and staging as well as of monitoring the effects of
treatment in the field of oncology. However, the uptake
of FDG is not specific [11]: uptake is seen not only in
normal organs but also in other non-neoplastic etiolo-
gies such as inflammatory, reactive, or infectious causes.
RDD, as a benign lymphoproliferative disorder, is gene-
rally believed to be FDG-avid. Clinically, RDD is com-
monly associated with lymphadenopathy of the cervical
region, but involvement of extranodal organs such as the
skin and paranasal sinuses is not rare [5]. Consequently,
the isolated or widespread FDG-avid lesions of RDD can
mimic malignancies and thus lead to a false image inter-
pretation. Therefore, RDD that exhibits massive lymph-
adenopathy or extranodal manifestations or both should
be considered in the differential diagnosis of a malignant
process, such as lymphoma or metastatic tumors.
An elevated serum titer of IgG4 is a surrogate mar-
ker for the recently characterized IgG4-RSD in multiple
extra-pancreatic sites with or without an accompanying
pancreatic lesion [12]. Pathologically, IgG4-RSD is an in-
flammatory or fibrosing disease process (or both) cha-
racterized by the presence of a prominent number of
IgG4+ plasma cells within the affected tissues [12]. Al-
though there is no consensus about the definite cutoff
limit for the number of IgG4+ plasma cells and the
ratio of IgG4+ to IgG+ cells as the diagnostic criteria
for IgG4-RSD, immunostaining shows an absolute num-
ber of IgG4+ cells of greater than 50 per high-powered
field, and an IgG4+/IgG+ cell ratio of greater than 40% is
well accepted by investigators [9].Generally, both RDD and IgG4-RSD have been proven
to be FDG-avid [13,14]. Although the mechanism of
RDD and IgG4-RSD with increased FDG uptake is not
certain, it has been well documented that variable ex-
pression of the glucose transporters may depend on ex-
pression of varying stress-related proteins or signaling
molecules induced by activated macrophages (histiocytes)
and lymphocytes [15]. In previous 18F-FDG PET reports,
RDD revealed as hypermetabolic lesions was found within
the thyroid, skin, and bones, where FDG-PET was used
for staging the supposed malignancy and surveying the ex-
tent of RDD [4,16]. For IgG4-RSD, FDG-PET was sug-
gested as an effective modality to provide extra-pancreatic
biopsy sites, monitor therapy, and demonstrate relapse
[14]. To the best of our knowledge, no report of FDG
PET/CT findings of RDD with IgG4+ plasma cell infiltra-
tion has been published, although a series of pathological
research has focused on this phenomenon. In our case,
the hypermetabolic soft-tissue nodule in the right breast
accompanied by multiple active pulmonary nodules mim-
icked breast malignancy with lung metastasis. Even in a
review of the PET/CT images, it seemed unfeasible to dis-
criminate the nature of FDG-avid breast RDD from car-
cinoma simply by the distribution pattern or intensity of
the FDG accumulation. In addition, the pancreas, hepato-
biliary system, and glandular organs, which are the most
common sites involved in IgG4-RSD, showed no abnor-
mal FDG accumulation in our patient. In this case, the
value of 18F-FDG PET/CT is mainly in localizing the
proper target sites for tissue biopsy and thereby confir-
ming the diagnosis and helping to adjust the clinical treat-
ment strategy.
It is interesting to find amyloid deposition rather than
abundant histiocytes or IgG4+ plasma cell accumulation
within pulmonary nodules. In addition, amyloidosis was
still observed in the connective tissues surrounding the
cervical LNs. For PET/CT images, the slight FDG uptake
at the edge of the solid pulmonary nodule was different
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matogenous metastatic lesions, which corresponded well
to the pathological findings of diffuse amyloid deposi-
tion accompanied by few histiocytic infiltrations at the
boundary of the samples. Pulmonary amyloidosis was
previously reported as multiple nodules with slight FDG
uptake and which were raised suspicion of metastasis
from a hidden malignancy [17]. Therefore, it is suggested
that, in the event of multiple irregular variable-sized
nodules with the special FDG distribution pattern in
both lungs, certain kinds of non-tumor diseases should
be taken into diagnostic consideration. Though rare,
amyloidosis ought to be kept in mind as a differential
diagnosis of metastatic lesions. In fact, amyloidosis is
caused by the extracellular deposition of pathological, in-
soluble, fibrillar proteins in organs and tissues. Secon-
dary amyloidosis is caused by the deposition of amyloid
originating from serum amyloid A, which is an acute-
phase protein produced in response to inflammation and
occurs most commonly among patients with chronic in-
flammatory diseases such as rheumatoid arthritis, juven-
ile rheumatoid arthritis, and inflammatory bowel disease
[18]. The reason for the amyloid deposition in this case
is not clear, but a plausible postulation is that it was
associated with the chronic inflammatory stimulation of
the mammary lesion and/or autoimmune abnormalities
represented by raised serum polyclonal immunoglobu-
lins and low titers of autoantibodies. Further studies may
be needed to explore the underpinning relationship bet-
ween serum amyloid A and autoimmune disease, RDD
and IgG4-RSD.
Conclusions
In summary, we report 18F-FDG PET/CT findings in a
case of breast RDD accompanied by IgG4+ plasma cell
infiltration. Although distinguishing benign lymphoplas-
macytic proliferation from other malignant lesions may
be difficult with 18F-FDG PET/CT in light of the pattern
and intensity of FDG uptake, our case highlights that
whole-body PET/CT imaging can display the extent of
the disease, help to complete staging, and provide func-
tional information about disease activity to guide biopsy
and can be used to monitor the therapeutic response
as well.
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